+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

The World Market for Infectious Disease Diagnostic Tests

  • ID: 2789937
  • Report
  • Region: Global
  • 300 Pages
  • Kalorama Information
1 of 4
Spread of Infections Fuels 14.5 Billion-Dollar Market for Diagnostic Tests

FEATURED COMPANIES

  • Abbott Diagnostics
  • CHROMagar
  • Hardy Diagnostics
  • Laboratorios CONDA
  • Nova Biomedical
  • Quanterix Corporation
  • MORE
The World Market for Infectious Disease Diagnostic Tests

World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also provided. Sales and forecasts of infectious disease reagents are made through to 2019. Emerging products and markets are described; key players and strategies discussed and competitive trends are analyzed.

The market information provided in this report includes the following:
  • Infectious Disease Immunoassay Sales by Region
  • Infectious Disease Immunoassays Market Share
  • Infectious Disease Molecular Sales by Region
  • Infectious Disease Blood Screening Sales by Region
  • Infectious Disease Blood Screening Sales by Region
  • Infectious Disease Blood Screening Test Market Shares
  • ID/AST Test Market by Type
  • Infectious Disease ID/AST Sales by Region
  • ID/AST Leader Market Shares
  • Infectious Disease Immunoassays by Type
  • Laboratory Infectious Disease Immunoassays Sales by Disease
The disparity in infectious disease test market growth rates is immediately evident between industrialized, first-world countries with established healthcare systems in North America, Europe and Asia (Japan) and countries of the developing world (China, India, most of Latin America). The developed world is projected to be held to an under-4% aver annual growth rate in terms of infectious disease test sales through 2020. Countries such as China, India and in Latin America, on the other hand, remain in the process of implementing rapid testing as part of infectious disease screening and molecular assays for the diagnosis and treatment of infectious diseases. Even established infectious disease testing tools such as culture ID/AST can expect more robust rates of growth in the developing world as labs update their microbiology testing to automated platforms and increase capacity to handle increased patient volume. A global report, The World Market for Infectious Disease Tests offers geographic breakouts for market categories.

In addition, the report provides market shares for major testing categories and profiles companies. Trends in infectious diseases and in products are discussed. The information contained in this report has been assembled from primary and secondary data. Secondary data was collected from peer review journals and industry generated press releases. Primary research was conducted via telephone conversation with selected diagnostic marketers of in vitro diagnostics to assess the current market and trends in laboratory medicine.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • CHROMagar
  • Hardy Diagnostics
  • Laboratorios CONDA
  • Nova Biomedical
  • Quanterix Corporation
  • MORE

ONE: EXECUTIVE SUMMARY Introduction The Globalization of Infectious Diseases Mounting Threat of Microbial Antibiotic Resistance Near-Patient Testing The Global Market for Infectious Disease Tests ID/AST Market Infectious Disease Immunoassay Market Blood Screening Assay Market Major Conclusions
TWO: INTRODUCTION TO INFECTIOUS DISEASES IN HEALTHCARE Introduction to the Evolving World of Infectious Disease Testing Public Health Response Funding Sources Leading Disease Threats Leading Infetious Disease Testing Technologies Point of View
THREE: TRENDS IN CLINICAL INFECTIOUS DISEASES Background The Globalization of Infectious Diseases Globalization Through Trade and Travel Disease Burdens in Developing World Vaccines Mounting Threat of Microbial Antibiotic Resistance Near-Patient Testing New Technology Platforms in Infectious Disease Testing Real-Time PCR Alternative Nucleic Acid Amplification Methods Loop-mediated isothermal amplification (LAMP) Nicking Enzyme Amplification Reaction (NEAR) Strand Displacement Amplification (SDA) Helicase Dependent Amplification (HDA) Nucleic Acid Sequence-Based Amplification (NASBA Transcription-mediated amplification (TMA) Sequencing Mass Spectrometry Flow Cytometry Conclusions
FOUR: OVERVIEW OF THE INFECTIOUS DISEASE TEST MARKET Background The World Market for Infectious disease Tests Infectious Disease Test Markets – ID/AST, Immunoassays, Molecular Assays Major Competitors in the Global Infectious Disease Test Market Market-Leading Infectious Diseases
FIVE: THE MARKET FOR MICROBIOLOGY ID/AST TESTING Background Liquid Microbiology and ID/AST Automation Market Analysis Regional Breakout Market Share Rapid Tests Microbial Identification and Antimicrobial Susceptibility Systems Chromogenic Media Blood Culture Vendor Developments in Blood Culture ID Testing Market Outlook for ID/AST Testing
SIX: THE MARKET FOR IMMUNOASSAYS Background Sepsis Serology Hepatitis HIV Mycology Parasitology Respiratory ToRCH Sexually Transmitted Diseases (STDs) Regional Breakout Market Outlook for Immunoassay Infectious Disease Testing
SEVEN: THE MARKET FOR MOLECULAR ASSAYS Background Market Analysis HAI Market HIV Market Hepatitis Market Chlamydia/Gonorrhea (CT/NG) HPV Respiratory Mycobacteria/TB Other CT/NG, HPV and Sexual Health / Women’s Health Healthcare-Acquired Infections (HAIs) / Antimicrobial Resistance (AMR) HIV Respiratory Market Outlook for Molecular Infectious Disease Testing
EIGHT: THE INFECTIOUS DISEASE BLOOD SCREENING MARKET Commonly Tested Pathogens in Blood Screening Market Analysis by Type Vendor Market Share Immunoassays Nucleic Acid Tests (NATs) Nucleic Acid Test Introductions and Innovations
NINE: COMPANY PROFILES Abbott Diagnostics Alere Beckman Coulter (Danaher) Becton, Dickinson & Co. (BD) bioMérieux Bio-Rad Laboratories Cepheid Chembio Diagnostic Systems Copan Diagnostics DiaSorin Molecular Blood Banking Grifols Blood Screening (Molecular PROCLEIX Tests) Hologic Molecular Cytology / Histology (HPV) Other Molecular (STIs, HIV, HCV, TB, Respiratory) Microbiology (AccuProbe Molecular Culture ID Tests) Blood Screening (Molecular PROCLEIX Tests) Meridian Bioscience OraSure Technologies Ortho-Clinical Diagnostics QIAGEN Molecular Diagnostics Immunoassays Quidel Corporation Roche Diagnostics Siemens Healthcare Diagnostics Thermo Fisher Scientific Trinity Biotech

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY Figure 1-1: European Antimicrobial Resistance (AMR) Heat Map By Country/Year(30 EEA Member Countries/2004-2013) – Methicillin Resistant S. aureus (MRSA) Figure 1-2: Worldwide Infectious Disease Test Market by Region Table 1-2: Worldwide Infectious Disease Test Market by Region/Country North America, Western Europe (EU), Japan, China, India, Latin America,Rest of the World (ROW) (2015-2020) Table 1-3: Worldwide Infectious Disease Test Market by Test Segment – LaboratoryImmunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020)
THREE: TRENDS IN CLINICAL INFECTIOUS DISEASES Table 3-1: Infectious Diseases of Globalization and Their Drivers Table 3-2: Disease Preventable Vaccines in 2015 Table 3-3: Preventive Vaccines in Development for Infectious Diseases (2015) Figure 3-1: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) – E. coli Resistance to Third-Generation Cephalosporins Figure 3-2: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) – K. pneumoniae Multidrug Resistance to Third-Generation Cephalosporins, Fluoroquinolones and Aminoglycosides Figure 3-3: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) – Methicillin Resistant S. aureus (MRSA) Table 3-4: Selected Advanced Antibiotic Resistance Tests Table 3-5: Selected Antibiotic Resistance Facts (CDC) Table 3-6: Selected Advanced Near-Patient Infectious Disease Testing Platforms Table 3-7: Selected Microorganisms and Their Associated Diseases Table 3-8: Selected Isothermal Amplification Methods and Platform Examples Table 3-9: Selected Next Generation Sequencers for Infectious Disease Applications Table 3-10: Selected Infectious Disease Sequencing Innovations Table 3-11: Selected Mass Spectrometry Microbiology Platforms Table 3-12: Selected Flow Cytometry Infectious Disease Applications
FOUR: OVERVIEW OF THE INFECTIOUS DISEASE TEST MARKET Table 4-1: Worldwide Infectious Disease Test Market by Region/Country – North America, Western Europe (EU), Japan, China, India, Latin America, Rest of the World (ROW) (2015-2020) Table 4-2: Worldwide Infectious Disease Test Market by Test Segment – Laboratory Immunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020) ($ millions) Table 4-3: Global Infectious Disease Test Market Shares – Abbott Diagnostics, Alere, Beckman Coulter, BD, bioMérieux, Bio-Rad Labs, Cepheid, DiaSorin, Grifols, Hologic, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Others (%) Table 4-4: Worldwide Infectious Disease Test Market by Major Diseases – HAI / AMR, Hepatitis, HIV, Respiratory, STDs / Women’s Health, Other Infectious Diseases (2015) ($ millions)
FIVE: THE MARKET FOR MICROBIOLOGY ID/AST TESTING Table 5-1: Microbiology Sample/Specimen Types Ranked by Average Volume Table 5-2: Worldwide ID/AST Sales by Segment – Panels and Reagents, Blood Culture, Chromogenic Media, Rapid Micro (2015-2020) ($ millions) Table 5-3: Worldwide ID/AST Sales by Region – North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020) ($ millions) Table 5-4: ID/AST Leader Market Shares – BD, Beckman Coulter, bioMérieux, Thermo Fisher Scientific, Others Table 5-5: Selected ID/AST System Innovations Table 5-6: Selected Chromogenic Media Innovations and Launches Table 5-7: Selected Blood Culture Innovations and Launches
SIX: THE MARKET FOR IMMUNOASSAYS Table 6-1: Selected Sepsis Serology Innovations Table 6-2: Worldwide Infectious Disease Immunoassay Sales by Segment – Lab-Based, Rapid / POC (2015-2020) ($ millions) Table 6-3: Worldwide Infectious Disease Immunoassay Sales by Region – North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020) ($ millions) Table 6-4 Alere, Beckman Coulter, bioMérieux, Bio-Rad Laboratories, DiaSorin, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Trinity Biotech, Others Table 6-5: Laboratory Infectious Disease Immunoassays Sales by Disease or Pathogen – Hepatitis, HIV, Mycology, Parasitology, Respiratory, Sepsis, Sexually Transmitted Diseases (STDs), ToRCH, Others (2015) Table 6-6: Selected Laboratory Infectious Disease Immunoassay Innovations Table 6-7: CLIA-Waived Infectious Disease Tests and Analytes Table 6-8: Rapid Infectious Disease Immunoassays Sales by Disease or Pathogen – C. difficile, E. coli, H. pylori, Hepatitis, HIV, Influenza, Malaria, Strep A, STDs, Others (2015) Table 6-9: Selected Rapid Infectious Disease Immunoassay Innovations
SEVEN: THE MARKET FOR MOLECULAR ASSAYS Table 7-1: Selected Moderate and Waived Complexity Molecular Infectious Disease Testing Platforms Table 7-2: Worldwide Molecular Infectious Disease Assay Sales by Disease Area – CT/NG, HAIs, Hepatitis, HIV, HPV, Mycobacteria/TB, Respiratory, Others (2015-2020) Table 7-3 bioMérieux, Cepheid, Hologic, QIAGEN, Roche Diagnostics, Siemens Healthcare Diagnostics, Others Table 7-4: Selected Molecular Sexual Health and Women’s Health Test Introductions and Innovations Table 7-5: Selected Molecular Healthcare-Acquired Infection (HAI) / Antimicrobial Resistance (AMR) Test Introductions and Innovations Table 7-6: Selected Molecular Hepatitis Test Introduction and Innovations Table 7-7: Selected Molecular HIV Test Introduction and Innovations Table 7-8: Selected Molecular Respiratory Infection Test Introduction and Innovations 178
EIGHT: THE INFECTIOUS DISEASE BLOOD SCREENING MARKET Table 8-1: Commonly Tested Pathogens in Blood Screening Table 8-2: Worldwide Infectious Disease Blood Screening Test Sales – Immunoassays and Nucleic Acid Tests (NATs) (2015-2020) ($ millions) Table 8-3: Infectious Disease Blood Screening Test Market Shares – Abbott Diagnostics, DiaSorin, Grifols, Hologic, Ortho-Clinical Diagnostics, Roche Diagnostics, Others Table 8-4: Selected Blood Screening Immunoassay Introductions and Innovations Nucleic Acid Tests (NATs) Table 8-5: Selected Blood Screening Nucleic Acid Test Introductions and Innovations.. 
NINE: COMPANY PROFILES Table 9-2: Alere Revenue (2011-2014) Table 9-3: Beckman Coulter Revenue (2011-2014) Table 9-4: Becton, Dickinson & Co. (BD) Revenue (FY 2011-2014) Table 9-5: bioMérieux Revenue (2011-2014) Table 9-6: Bio-Rad Laboratories Revenue (2011-2014) Table 9-7: Cepheid Revenue (2011-2014) Table 9-8: Chembio Diagnostics Systems Revenue (2011-2014) Table 9-9: DiaSorin Revenue (2011-2014) Table 9-10: Grifols Revenue (2011-2014) Table 9-11: Hologic Revenue (FY 2011-2014) Table 9-12: Meridian Bioscience Revenue (2011-2014) Table 9-13: OraSure Technologies Revenue (2011-2014) Table 9-14: Ortho-Clinical Diagnostics Revenue (2011-2014) Table 9-15: QIAGEN Revenue (2011-2014) Table 9-16: Quidel Corporation Revenue (2011-2014) Table 9-17: Roche Diagnostics Revenue (2011-2014) Table 9-18: Siemens Healthcare Diagnostics Revenue (FY 2011-2014) Table 9-19: Thermo Fisher Scientific Revenue (2011-2014) Table 9-20: Trinity Biotech Revenue (2011-2014)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • CHROMagar
  • Hardy Diagnostics
  • Laboratorios CONDA
  • Nova Biomedical
  • Quanterix Corporation
  • MORE
Increasing incidence of infectious disease is expected to make the market for infectious disease tests among the most dynamic in the in vitro diagnostics industry. The world market for infectious disease tests is estimated at $14.5 billion in 2012 and should grow at a slightly higher rate than the rest of the diagnostics market.

The report states that no one technology can satisfy the needs for all infectious disease diagnostics. Therefore for the foreseeable future, laboratories will use a mix of traditional identification and antimicrobial sensitivity tests (ID/AST) and immunoassays for most routine testing and molecular tests for hard to culture pathogens and for the most time critical situations. Molecular tests also provide crucial genus and species specific information necessary in the investigation of epidemics and disease outbreaks. But innovations in traditional ID/AST techniques, immunoassays and culture media allow these test segments to hold their own in this fast paced diagnostics industry. And the whole market, according to the report, will benefit from a favorable reimbursement trend.

Seven of the biggest killers worldwide, TB, malaria, hepatitis, and, in particular, HIV/AIDS continue to surge, with HIV/AIDS and TB likely to account for the overwhelming majority of deaths from infectious diseases in developing countries by 2020. Acute lower respiratory infections including, pneumonia and influenza, STDs, HAIs, diarrheal diseases and measles, are major public health problems, worldwide.

Improvements in detection time and the development of accurate rapid screening tests permits more effective treatment choices, which is a positive sign for the market for IVD test products. The report predicts that in the next 5-10 years from now the emphasis will be on rapid screening tests to detect pathogens and nucleic acid tests to hone in on the appropriate treatment to be given.

The report, The World Market for Infectious Disease Diagnostic Tests contains more information and market breakouts by specific disease segments. Profiles of hundreds of companies in infectious disease testing are included as part of the report's coverage.
Note: Product cover images may vary from those shown
5 of 4
- Abbott Diagnostics
- Beckman Coulter Inc./Danaher
- Becton, Dickinson and Company (BD)
- BD GeneOhm
- bioMérieux Inc.
- Bio-Rad Laboratories Inc.
- Gen-Probe Inc.
- Hologic, Inc.
- Ortho Clinical Diagnostics
- QIAGEN N.V.
- Roche Diagnostics
- Siemens Healthcare Diagnostics
- Thermo Fisher Scientific Inc.
- Bruker BioSciences Corporation
- CHROMagar
- Copan Diagnostics Inc.
- Hardy Diagnostics
- Laboratorios CONDA
- Lab M
- Liofilchem S.R.L.
- Mindray Bio-Medical Electronics Co., Ltd
- Oxoid
- Serosep Limited
- Astra Biotech GmbH
- Cavidi AB
- Cellestis Ltd
- Corgenix Medical Corporation
- Diagnostic HYBRIDS, Inc. (DHI)
- DiaSorin S.p.A
- Diaxonhit
- Euroimmun AG
- Fujirebio Diagnostics, Inc.
- Gold Standard Diagnostics
- Immunetics Inc.
- Immuno-Mycologics (IMMY)
- InBios International, Inc.
- Luminex Corporation
- MBio Diagnostics, Inc.
- Meridian Bioscience, Inc.
- illumigene Molecular
- Meridian Life Science
- J.Mitra & Co. Pvt Ltd
- MP Biomedicals LLC
- Nova Biomedical
- OncoHealth Corporation
- Orgentec Diagnostika
- Oxford Immunotec Ltd.
- Pro-Lab Diagnostics
- Quanterix Corporation
- Quidel Corporation
- Sekisui Diagnostics (formerly Genzyme Diagnostics)
- TECHLAB Inc.
- Trinity Biotech plc
- The Tulip Group
- Vircell, SL
Note: Product cover images may vary from those shown
Adroll
adroll